Drug-adverse related events in emergency department : Epidemiological,clinical profile and prognosis

##plugins.themes.academic_pro.article.sidebar##

Published Sep 29, 2017
Download
pdf
Vol. 95 No. 1 (2017): Issue Jan 2017

##plugins.themes.academic_pro.article.main##

Rym Hamed
Samia Mefteh
Sarra Jouini
Khaled Saïdi
Dorra Chtourou
Amel Maaref
Béchir Bouhajja

Abstract

Introduction: Adverse-drug events (ADe) are frequent in emergency medicine and remain misdiagnosed depending on the clinical polymorphism and the underlying comorbidities. Older patients with multiple comorbidities and polypharmacy are more frequently affected and makes poor prognosis.

Aim of the study : The aim of this study was to evaluate the epidemiology of ADe in the emergency department (ED) visits and to identify the prognostic value mortality within 30 days.

Methods: Prospective, monocentric study. Patients were included if they met criteria of aADe. We evaluated severity and mortality at 30 days. Moreover, misuse and preventabilty were studied.Results: We included 159 cases within 113,272 ED visits. Mean age = 64 ± 19 years, sex ratio =0.6.The average number of drugs was 4.5 ± 3. Polymedication was found in 54%. In 10 cases, the prescription contained twice the same molecule. A double ADe was found in 11 patients. We identified 55 cases of misuse, 94% of them were due to physician. An interaction was found in 23 patients. Improper prescription with age, renal function or presence of contra-indications was found in 46 patients. In 41% cases, ADR events were preventable. An ADR event was considered severe in 44% of cases and 30-Days mortality’s rate was 9.4%. Drugs n (%): Anticoagulants 53(34,6); Antihypertensive 29(19); Antiarrhythmic 15(10). Multivariate analysis of mortality at day 30: Misuse and polyapthology were independent predictors; Respective Odds ratios: (OR: 2.6; 95% CI [1.25-5.38]; p=0,001) and (OR 2.31; 95% CI [1,16 - 4,61]; p=0,017).

Conclusion: Drug-related ED visits are common in elderly. ADe is severe in 44% cases and preventable in 41%. Mortality rate was 9,4%. Misuse, polypharmacy and comorbidities were independent predictors of severity and mortality.

Keywords:

Drug-related events, Emergency department, epidemiology, treatment, mortality, prognosis

##plugins.themes.academic_pro.article.details##

References

  1. Nickel CH, Ruedinger JM, Messmer AS, Maile S, Peng A, Bodmer M, et al. Drug - related emergency department visits by elderly patients presenting with non-specific complaints. Scand J Trauma ResuscEmerg Med2013;10:21-5.
  2. Chousterman B, Pirracchio R. De l'iatrogénèse aux erreurs médicales : mise au point et approche analytique. Ann Fr Anesth Réanimation 2011;30:914-22.
  3. Madeira S, Melo M, Porto J, Monteiro S, Pereira de Moura JM, Alexandrino MB, et al. The diseases we cause: Iatrogenic illness in a department of internal medicine. Eur J Intern Med 2007;18:391-9.
  4. Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, et al. Incidence of Adverse Events and Negligence in Hospitalized Patients. N Engl J Med 1991;324:370-6.
  5. Health care in the elderly: report of the Technical Group on Use of Medicaments by the Elderly. World Health OrganizationDrugs 1981;22:279-94.
  6. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studiesJAMA1998 :15;279:1200-5.
  7. Bouhaja B, Mermech M, Mestiri T, Ben Ayed M, Dhaouadi MZ, Ben Ammar MS. La pathologie iatrogène en réanimation: étude prospective. Réanimation Urgences 1999 ;8:319-26.
  8. Leape LL. Reporting of Adverse Events.N Engl J Med2002;347:1633-8.
  9. Bogé A, Lorgis L, Dautriche A, Bonnet M, Gudjoncik A, Buffet P, et al. Les admissions pour iatrogénie sévère en unité de soins intensifs de cardiologie : étude prospective sur 7244 patients. Ann CardiolAngéiologie2013;62:75-81.
  10. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population. Am J Emerg Med1996;14:447-50.
  11. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA2003;290:1868-74.
  12. Roblot P, de Bayser L, Barrier J, Maréchaud R, Becq-Giraudon B. [“Primum non nocere”. Prospective study of 115 cases of iatrogenic diseases collected over one year in 106 patients]. Rev Med Interne 1994;15:720-6
  13. Hohl CM, Robitaille C, Lord V, Dankoff J, Colacone A, Pham L, et al. Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department.AcadEmerg Med Off J SocAcadEmerg Med 2005;12:197-205.
  14. Steel K, Gertman PM, Crescenzi C, Anderson J. Iatrogenic Illness on a General Medical Service at a University Hospital. N Engl J Med 1981;304:638-42.
  15. Trunet P, Le Gall JR, Lhoste F, Regnier B, Saillard Y, Carlet J, et al. The role of iatrogenic disease in admissions to intensive care. JAMA 1980;244:2617-20.
  16. Thomas EJ, Studdert DM, Burstin HR, Orav EJ, Zeena T, Williams EJ, et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care2000;38:261-71.
  17. Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The Quality in Australian Health Care Study. Med J Aust1995;163:458-71.
  18. Raimondeau J, Bouhour JB, Gachard N, Rouet F, Reyrolle L. [Surveillance of iatrogenic complications in a department of cardiology. Thoughts about a preventive strategy]. Ann CardiolAngéiologie1993;42:345-50.
  19. Davis P, Lay-Yee R, Briant R, Ali W, Scott A, Schug S. Adverse events in New Zealand public hospitals I: occurrence and impact. N Z Med J 2002;115:U271.
  20. Darchy B, Le Mière E, Figuérédo B, Bavoux E, Domart Y. Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences. Arch Intern Med 1999;159:71-8.
  21. Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001;322:517-9.
  22. Baker GR, Norton PG, Flintoft V, Blais R, Brown A, Cox J, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ Can Med Assoc J JAssocMedicale Can 2004 ;170:1678-86.
  23. Soop M, Fryksmark U, Köster M, Haglund B. The incidence of adverse events in Swedish hospitals: a retrospective medical record review study. Int J Qual Health Care JIntSocQual Health Care ISQua2009 ;21:285-91.
  24. Hoonhout LHF, de Bruijne MC, Wagner C, Zegers M, Waaijman R, Spreeuwenberg P, et al. Direct medical costs of adverse events in Dutch hospitals. BMC Health Serv Res 2009;9:27.
  25. Michel P, Quenon JL, Djihoud A, Tricaud-Vialle S, de Sarasqueta AM. French national survey of inpatient adverse events prospectively assessed with ward staff. QualSaf Health Care 2007;16:369-77.
  26. Aranaz-Andrés JM, Aibar-Remón C, Vitaller-Murillo J, Ruiz-López P, Limón-Ramírez R, Terol-García E, et al. Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events. J Epidemiol Community Health 2008 ;62:1022-9.
  27. Queneau P, Chabot JM, Rajaona H, Boissier C, Grandmottet P. [Iatrogenic illness observed in the hospital environment. I. A report of 109 cases collected in a cross-sectional APNET study]. Bull Académie Natl Médecine1992 ;176:511-26.
  28. Kane-Gill S, Rea RS, Verrico MM, Weber RJ. Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm 2006;63:1876-81.
  29. Rothschild JM, Landrigan CP, Cronin JW, Kaushal R, Lockley SW, Burdick E, et al. The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 2005 ;33:1694-700.
  30. Morimoto T, Sakuma M, Matsui K, Kuramoto N, Toshiro J, Murakami J, et al. Incidence of adverse drug events and medication errors in Japan: the JADE study. J Gen Intern Med 2011 ;26:148-53.
  31. Bouafia N, Bougmiza I, Bahri F, Letaief M, Astagneau P, Njah M. Ampleur et impact des évènements indésirables graves liés aux soins: étude d'incidence dans un hôpital du Centre-Est tunisien. Pan Afr Med J [Internet]. 2013 [cited 2015 Feb 23];16. Available from: http://www.panafrican-med-journal.com/content/article/16/68/full/
  32. Vogt-Ferrier N. Older patients, multiple comorbidities, polymedication… should we treat everything? EurGeriatrMed 2011 ;2:48-51.
  33. Flaherty JH, Perry HM, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A BiolSci Med Sci 2000;55:M554-9.
  34. Cecile M, Seux V, Pauly V, Tassy S, Reynaud-Levy O, Dalco O, et al. Accidents iatrogènes médicamenteux chez le sujet âgé hospitalisé en court séjour gériatrique : étude de prévalence et des facteurs de risques. Rev Med Int. 2009;30:393-400.
  35. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä S-L, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J ClinEpidemiol2002 ;55:809-17.
  36. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J ClinPharmacol 1998;45:301-8.
  37. Bonnet-Zamponi D, d' Arailh L, Konrat C, Delpierre S, Lieberherr D, Lemaire A, et al. Drug-related readmissions to medical units of older adults discharged from acute geriatric units: results of the Optimization of Medication in AGEd multicenter randomized controlled trial. J Am Geriatr Soc 2013;61:113-21.
  38. Poidevin A, Egard M, Guiot P, Kuteifan K. L'évènement indésirable grave : un motif d'admission fréquent en réanimation. Ann Fr Anesth Réanimation 2014 ;33:503-7.
  39. Garry DA, McKechnie SR, Culliford DJ, Ezra M, Garry PS, Loveland RC, et al. A prospective multicentre observational study of adverse iatrogenic events and substandard care preceding intensive care unit admission (PREVENT). Anaesthesia 2014;69:137-42.